IntraBio

IntraBio is a leading biopharmaceutical company that works on new treatments for rare and brain-related diseases. The company is built on the expertise of its founders from the University of Oxford and the University of Munich, focusing on diseases that currently have few or no treatments. IntraBio's research is advanced and aims at improving treatments for various neurological and aging-related conditions. Their work involves cutting-edge science in areas like genetics and brain health, with the goal of developing effective medications for these challenging diseases.

NewsHeat chart

  • Week
  • Month
  • Year
  • Media news
  • Corp news
Click to unlock the chart

The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice

Company Valuation

  • Valuation
  • Share Price
  • Cumulative Funding

The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.

Funding Round
Funding Amount
Post-Money Valuation
Share Price
Venture23 Mar, 2024
***
***
***
Venture17 Aug, 2018
***
***
***

*** - To view the data, please log into your account or create a new one.

News related to IntraBio1

Filter by
Sort by
IntraBio
Mar 23, 2024 •Show on chart

UK biopharma company IntraBio moves HQ to Austin, raises $40M

U.K.-based IntraBio is moving its HQ to the city. ...

https://www.bizjournals.com/austin/news/2024/03/26/uk-biopharma-intrabio-hq-austin.html